NCT00706589 - Aripiprazole in Children and Adolescents With Chronic Tic Disorder or Tourette's Disorder | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

April 30, 2010

Study Completion Date

April 30, 2010

Conditions

Chronic Motor or Vocal Tic DisorderTourette's Disorder

Interventions

DRUG

aripiprazole

Initial dose : 2mg, Maximum dose : 20mg

DRUG

placebo

Initial dose: 2mg, Maximum dose:20mg

Trial Locations (6)

Inha University Hospital, Inchon

Seoul National University Hospital, Seoul

Yonsei University Severance Hospital, Seoul

Samsung Medical Center, Seoul

Asan Medical Center, Seoul

Chung-Ang Univ. Medical center, Seoul